{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:17:25Z","timestamp":1755224245994,"version":"3.43.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.7759\/cureus.89878","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:02:52Z","timestamp":1755000172000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical Expression of SGLT2 in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.7759","author":[{"given":"Shristi","family":"Butta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan S","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013, 12:152. 10.1186\/1476-4598-12-152","journal-title":"Mol Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant DA","year":"2010","unstructured":"Tennant DA, Dur\u00e1n RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010, 10:267-77. 10.1038\/nrc2817","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11030562","article-title":"Pancreatic ductal adenocarcinoma: epidemiology and risk factors","volume":"11","author":"Ushio J","year":"2021","unstructured":"Ushio J, Kanno A, Ikeda E, et al.. Pancreatic ductal adenocarcinoma: epidemiology and risk factors. Diagnostics (Basel). 2021, 11:562. 10.3390\/diagnostics11030562","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Tempero MA","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, et al.. Pancreatic adenocarcinoma, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:439-57. 10.6004\/jnccn.2021.0017","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang J","year":"2020","unstructured":"Yang J, Ren B, Yang G, et al.. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020, 77:305-21. 10.1007\/s00018-019-03278-z","journal-title":"Cell Mol Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy V","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009, 121:29-40. 10.1016\/j.pharmthera.2008.09.005","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2019.08.06","article-title":"The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition?","volume":"9","author":"Shin DW","year":"2020","unstructured":"Shin DW, Kim J. The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition?. Hepatobiliary Surg Nutr. 2020, 9:98-100. 10.21037\/hbsn.2019.08.06","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller KD","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, et al.. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016, 66:271-89. 10.3322\/caac.21349","journal-title":"CA Cancer J Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.07.035","article-title":"SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis","volume":"519","author":"Ren D","year":"2021","unstructured":"Ren D, Sun Y, Zhang D, Li D, Liu Z, Jin X, Wu H. SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis. Cancer Lett. 2021, 519:277-88. 10.1016\/j.canlet.2021.07.035","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235811","article-title":"SGLT-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives","volume":"14","author":"Dutka M","year":"2022","unstructured":"Dutka M, Bobi\u0144ski R, Francuz T, et al.. SGLT-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives. Cancers (Basel). 2022, 14:5811. 10.3390\/cancers14235811","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio C","year":"2015","unstructured":"Scafoglio C, Hirayama BA, Kepe V, et al.. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015, 112:E4111-9. 10.1073\/pnas.1511698112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7411-1_28","article-title":"Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?","volume":"789","author":"Mayer A","year":"2013","unstructured":"Mayer A, Vaupel P. Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?. Adv Exp Med Biol. 2013, 789:203-9. 10.1007\/978-1-4614-7411-1_28","journal-title":"Adv Exp Med Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i9-S.7923","article-title":"Epidemiology and risk factors of pancreatic cancer","volume":"89","author":"Capasso M","year":"2018","unstructured":"Capasso M, Franceschi M, Rodriguez-Castro KI, et al.. Epidemiology and risk factors of pancreatic cancer. Acta Biomed. 2018, 89:141-6. 10.23750\/abm.v89i9-S.7923","journal-title":"Acta Biomed"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.02.058","article-title":"Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: changes and advances, a review","volume":"52","author":"Khadka R","year":"2018","unstructured":"Khadka R, Tian W, Hao X, Koirala R. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: changes and advances, a review. Int J Surg. 2018, 52:342-6. 10.1016\/j.ijsu.2018.02.058","journal-title":"Int J Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve P","year":"2015","unstructured":"Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015, 44:186-98. 10.1093\/ije\/dyu240","journal-title":"Int J Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000375164","article-title":"Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis","volume":"101","author":"Haugvik SP","year":"2015","unstructured":"Haugvik SP, Hedenstr\u00f6m P, Kors\u00e6th E, et al.. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology. 2015, 101:133-42. 10.1159\/000375164","journal-title":"Neuroendocrinology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i30.4861","article-title":"Is diabetes mellitus a risk factor for pancreatic cancer?","volume":"19","author":"Pezzilli R","year":"2013","unstructured":"Pezzilli R, Pagano N. Is diabetes mellitus a risk factor for pancreatic cancer?. World J Gastroenterol. 2013, 19:4861-6. 10.3748\/wjg.v19.i30.4861","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000382","article-title":"Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants","volume":"33","author":"Giri B","year":"2017","unstructured":"Giri B, Sethi V, Dudeja V, Banerjee S, Livingstone A, Saluja A. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants. Curr Opin Gastroenterol. 2017, 33:404-10. 10.1097\/MOG.0000000000000382","journal-title":"Curr Opin Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9686-3","article-title":"Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies","volume":"22","author":"Li D","year":"2011","unstructured":"Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011, 22:189-97. 10.1007\/s10552-010-9686-3","journal-title":"Cancer Causes Control"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06938.x","article-title":"Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan","volume":"27","author":"Liao KF","year":"2012","unstructured":"Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol. 2012, 27:709-13. 10.1111\/j.1440-1746.2011.06938.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2018.0271","article-title":"Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications","volume":"45","author":"Kobayashi M","year":"2019","unstructured":"Kobayashi M, Uematsu T, Tokura Y, et al.. Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications. Int Braz J Urol. 2019, 45:169-78. 10.1590\/S1677-5538.IBJU.2018.0271","journal-title":"Int Braz J Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-021-02625-z","article-title":"Correction to: SGLT2 and cancer","volume":"473","author":"Wright EM","year":"2021","unstructured":"Wright EM. Correction to: SGLT2 and cancer. Pflugers Arch. 2021, 473:1807. 10.1007\/s00424-021-02625-z","journal-title":"Pflugers Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367838-immunohistochemical-expression-of-sglt2-in-pancreatic-ductal-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:02:53Z","timestamp":1755000173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367838-immunohistochemical-expression-of-sglt2-in-pancreatic-ductal-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.89878","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}